ARCHIVED: NOT AVAILABLE FOR CREDIT
The State of the Dysplastic Nevus in the 21st Century

 

The dysplastic nevus has been the source of much controversy and debate since the term was coined in the 1970’s. Many studies regarding this histologic entity have been performed over the years and the debate still exists about proper diagnosis and management of these nevi. The lecture will elucidate some of the recent advances in understanding these distinct entities and their relationship to melanoma risk.

Originally presented on February 12, 2019, in Park City, Utah.

Lecture Presenter

Keith Duffy, MD

Keith Duffy, MD

Associate Professor of Dermatology
University of Utah School of Medicine
Investigator
Huntsman Cancer Institute

Keith Duffy, MD, is an associate professor in the Department of Dermatology at the University of Utah School of Medicine and a Huntsman Cancer Institute investigator. Dr. Duffy's clinical interests include Mohs surgery (a microscopic technique that allows skin cancers to be removed with very narrow surgical margins), facial reconstruction post-Mohs surgery, and diagnostic dermatopathology (the study of skin diseases at the microscopic level). He is board certified in Dermatology and Dermatopathology. He is also a Fellow of the American Academy of Dermatology, the American College of Mohs Surgery and Cutaneous Oncology, and the American Society of Dermatopathology. His research interests include non-melanoma skin cancers (basal cell carcinoma and squamous cell carcinoma), melanoma, treatment of rare skin cancers, and wound healing.

Objectives

After this presentation, participants will be able to:

  • Describe the unique genetic mutations underlying many dysplastic nevi
  • Discuss the controversy that exists in sampling and treating these lesions
  • Recognize different approaches to everyday pathology sign out of these cases

Sponsored by:

University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories